Dihydroartemisinin Sensitizes Mutant p53 (R248Q)-Expressing Hepatocellular Carcinoma Cells to Doxorubicin by Inhibiting P-gp Expression
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dihydroartemisinin Sensitizes Mutant p53 (R248Q)-Expressing Hepatocellular Carcinoma Cells to Doxorubicin by Inhibiting P-gp Expression
Authors
Keywords
-
Journal
Biomed Research International
Volume 2019, Issue -, Pages 1-10
Publisher
Hindawi Limited
Online
2020-01-01
DOI
10.1155/2019/8207056
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Dihydroartemisinin Inhibits Proliferation and Induces Apoptosis of Human Hepatocellular Carcinoma Cell by Upregulating Tumor Necrosis Factor via JNK/NF-κB Pathways
- (2019) Long Wu et al. Evidence-based Complementary and Alternative Medicine
- Enhancing the Efficacy and Safety of Doxorubicin against Hepatocellular Carcinoma through a Modular Assembly Approach: The Combination of Polymeric Prodrug Design, Nanoparticle Encapsulation, and Cancer Cell-Specific Drug Targeting
- (2018) Li Xu et al. ACS Applied Materials & Interfaces
- Dihydroartemisinin suppresses STAT3 signaling and Mcl-1 and Survivin expression to potentiate ABT-263-induced apoptosis in Non-small Cell Lung Cancer cells harboring EGFR or RAS mutation
- (2018) Xiaohui Yan et al. BIOCHEMICAL PHARMACOLOGY
- Advances in Studies of P-Glycoprotein and Its Expression Regulators
- (2018) Kentaro Yano et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Dihydroartemisinin induced caspase-dependent apoptosis through inhibiting the specificity protein 1 pathway in hepatocellular carcinoma SK-Hep-1 cells
- (2018) Eunji Im et al. LIFE SCIENCES
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Dihydroartemisinin Increases the Sensitivity of Photodynamic Therapy Via NF-κB/HIF-1α/VEGF Pathway in Esophageal Cancer Cell in vitro and in vivo
- (2018) Yanjing Li et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Mutant p53 Protein and the Hippo Transducers YAP and TAZ: A Critical Oncogenic Node in Human Cancers
- (2017) et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Mutant p53 in Cancer: Accumulation, Gain-of-Function, and Therapy
- (2017) Xuetian Yue et al. JOURNAL OF MOLECULAR BIOLOGY
- Dihydroartemisinin and gefitinib synergistically inhibit NSCLC cell growth and promote apoptosis via the Akt/mTOR/STAT3 pathway
- (2017) Hong Jin et al. Molecular Medicine Reports
- Census and evaluation of p53 target genes
- (2017) M Fischer ONCOGENE
- Systemic Therapy for Hepatocellular Carcinoma: 2017 Update
- (2017) Masatoshi Kudo ONCOLOGY
- p53 loss-of-heterozygosity is a necessary prerequisite for mutant p53 stabilization and gain-of-function in vivo
- (2017) Evguenia M Alexandrova et al. Cell Death & Disease
- Mechanistic diversity in ATP-binding cassette (ABC) transporters
- (2016) Kaspar P Locher NATURE STRUCTURAL & MOLECULAR BIOLOGY
- SH3GL1 inhibition reverses multidrug resistance in colorectal cancer cells by downregulation of MDR1/P-glycoprotein via EGFR/ERK/AP-1 pathway
- (2016) Haitao Guan et al. TUMOR BIOLOGY
- Mechanistic diversity in ATP-binding cassette (ABC) transporters
- (2016) Kaspar P Locher NATURE STRUCTURAL & MOLECULAR BIOLOGY
- The Interactions of P-Glycoprotein with Antimalarial Drugs, Including Substrate Affinity, Inhibition and Regulation
- (2016) S M D K Ganga Senarathna et al. PLoS One
- Dihydroartemisinin induces apoptosis preferentially via a Bim-mediated intrinsic pathway in hepatocarcinoma cells
- (2015) Guiqi Qin et al. APOPTOSIS
- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Hot Spot Mutation in TP53 (R248Q) Causes Oncogenic Gain-of-Function Phenotypes in a Breast Cancer Cell Line Derived from an African American patient
- (2015) Nataly Shtraizent et al. International Journal of Environmental Research and Public Health
- Multi-drug resistance in cancer chemotherapeutics: Mechanisms and lab approaches
- (2014) Qiong Wu et al. CANCER LETTERS
- Atovaquone and quinine anti-malarials inhibit ATP binding cassette transporter activity
- (2014) Sanna R Rijpma et al. MALARIA JOURNAL
- Expanding the prion concept to cancer biology: dominant-negative effect of aggregates of mutant p53 tumour suppressor
- (2013) Jerson L. Silva et al. BIOSCIENCE REPORTS
- Dihydroartemisinin exhibits antitumor activity toward hepatocellular carcinoma in vitro and in vivo
- (2012) Chris Zhiyi Zhang et al. BIOCHEMICAL PHARMACOLOGY
- Molecular Pathways: Regulation and Therapeutic Implications of Multidrug Resistance
- (2012) K. G. Chen et al. CLINICAL CANCER RESEARCH
- Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma
- (2012) Hashem B. El-Serag GASTROENTEROLOGY
- Mutant p53: one name, many proteins
- (2012) W. A. Freed-Pastor et al. GENES & DEVELOPMENT
- Growth inhibitory effect of dihydroartemisinin on Bcr/Abl+ chronic myeloid leukemia K562 cells involve AKT, ERK and NF-κB modulation
- (2012) Jun Lee et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Various p53 mutant proteins differently regulate the Ras circuit to induce a cancer-related gene signature
- (2012) Hilla Solomon et al. JOURNAL OF CELL SCIENCE
- Clitocine Reversal of P-Glycoprotein Associated Multi-Drug Resistance through Down-Regulation of Transcription Factor NF-κB in R-HepG2 Cell Line
- (2012) Jianguo Sun et al. PLoS One
- Functional Significance of Genetic Polymorphisms in P-glycoprotein (MDR1, ABCB1) and Breast Cancer Resistance Protein (BCRP, ABCG2)
- (2011) Ichiro Ieiri Drug Metabolism and Pharmacokinetics
- Multiple Drug Resistance Mechanisms in Cancer
- (2010) Bruce C. Baguley MOLECULAR BIOTECHNOLOGY
- Experimental Therapy of Hepatoma with Artemisinin and Its Derivatives: In vitro and In vivo Activity, Chemosensitization, and Mechanisms of Action
- (2008) J. Hou et al. CLINICAL CANCER RESEARCH
- Qinghaosu (Artemisinin): The Price of Success
- (2008) N. J. White SCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now